Keyphrases
Respiratory Syncytial Virus Infection
100%
Respiratory Syncytial Virus
100%
Exchange Protein Directly Activated by cAMP
100%
Epac2
66%
Virus Replication
44%
Cyclic Adenosine Monophosphate (cAMP)
22%
Exchange Protein
22%
ESI-09
22%
Specific Genes
11%
Pharmacological Strategies
11%
Public Health Risk
11%
Molecular Mechanism
11%
Inflammation
11%
Chemokines
11%
Viral Infection
11%
Effective Treatment
11%
Virus
11%
Inflammatory Cytokines
11%
Transcription Factor
11%
NF-B
11%
Respiratory Infection
11%
Novel Functions
11%
Epithelial Cells
11%
Lung Disease
11%
Protein Kinase
11%
Specific Inhibitor
11%
High-risk Adults
11%
Gene Knockout
11%
Host Response
11%
Putative Drug Targets
11%
Bronchiolitis
11%
Young children
11%
Therapeutic Target
11%
Innate Inflammatory Response
11%
Asthma Exacerbation
11%
Pneumonia
11%
Dominant Role
11%
Epac1
11%
Isoform-specific
11%
Specific Treatment
11%
Cell Treatment
11%
Immunology and Microbiology
Human Respiratory Syncytial Virus
100%
Respiratory Syncytial Virus Infection
100%
Viral Replication
44%
Electrospray Ionization
22%
Health
11%
Development
11%
Inflammation
11%
Inflammation Response
11%
Lung
11%
Cells
11%
Chemokine
11%
Vaccine Efficacy
11%
Immune Response
11%
Mortality
11%
Morbidity
11%
Experiment
11%
Virus
11%
Proinflammatory Cytokine
11%
Viral Disease
11%
Bronchiolitis
11%
Asthma Exacerbation
11%
Gene Knockdown
11%
INIS
proteins
100%
viruses
100%
inflammation
16%
amp
16%
knock-out reactions
8%
public health
8%
diseases
8%
genes
8%
children
8%
risks
8%
adults
8%
induction
8%
cytokines
8%
lungs
8%
asthma
8%
kinases
8%
vaccines
8%
mortality
8%
morbidity
8%
host
8%
pneumonia
8%
Biochemistry, Genetics and Molecular Biology
Protein
100%
Human Respiratory Syncytial Virus
100%
Health
9%
Development
9%
Experiment
9%
Morbidity
9%
Mortality
9%
Virus
9%
Chemokine
9%
Proinflammatory Cytokine
9%
Immune Response
9%
Isoform
9%
Protein Kinase A
9%
Gene Knockdown
9%